Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.
提供了抑制聚
腺苷酸
核糖合酶(PARP)活性的化合物和制药组合物。这些化合物在治疗各种疾病、状况和损伤方面具有用处,如中风、心肌梗死、各种器官的缺血再灌注损伤、创伤性脑损伤、动脉粥样硬化、炎症性疾病和癌症。